Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Liberty Health Sciences Inc. announces operational updates to increase patient accessibility in Florida

Liberty Health Sciences Inc.
Posted on: 18 Sep 17
Liberty Health Sciences Inc. announces operational updates to increase patient accessibility in Florida

Canada NewsWire

TORONTO, Sept. 18, 2017

Two dispensaries set to open in December 2017; Delivery service expanded to include South Florida

TORONTO, Sept. 18, 2017 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS) (OTCBB:SCQBF) ("Liberty" or the "Company") announced today that it has secured locations for two medical cannabis dispensaries that are scheduled to open in December 2017. The dispensaries will be strategically located in The Villages and Fort Lauderdale, Florida, with more locations planned in the near future. The dispensary operations and plans are being finalized and will be submitted to the Florida Department of Health, Office of Medical Marijuana Use for approval in accordance with state law.

Liberty is dedicated to providing patients with reasonably priced and accessible medical cannabis. Therefore, effective immediately, Liberty has expanded its delivery offering to service South Florida, ensuring patients in the region have convenient access to its high-quality, clean and safe pharmaceutical grade medical cannabis. Liberty has also implemented universal compassionate pricing to ensure that all patients, regardless of income level, can benefit from its medical cannabis products.

"The opening of Liberty dispensaries and the expansion of our delivery system to South Florida represent an important step in our Florida growth strategy as we look to provide patients with more options to access our pharmaceutical grade products," said George Scorsis, Director and CEO of Liberty. "Our goal is to ensure that the dispensaries are patient-centric, providing not only access to high-quality medical cannabis, but also comprehensive education and resources to inform patients on cannabis use as a safe alternative to treat symptoms related to several medical ailments. Aphria products will be available for purchase at our dispensary locations."

According to state reports, Florida continues to see a surge in the number of patients being treated with medical cannabis. From June to August 2017, the number of Florida patients has doubled, from under 17,000 to over 33,0001. Liberty expects this number to grow exponentially as more physicians recommend cannabis as a treatment option and more conditions qualify for the treatment.

"Our dispensary locations are strategic by design," continued Scorsis. "We follow a strict geographic targeting methodology focusing on locations with a substantial population and a significant number of prescribing physicians.

About the new dispensary locations:

The Villages

With a population of 150,000 people and a median resident age of 60, the Villages is one of the largest planned retirement/senior living communities in the United States. The medical demographics provide a large patient pool to whom Liberty may provide its high-quality medical cannabis products.

Fort Lauderdale

Liberty's Fort Lauderdale location is ideal for the nearly 2-million residents of east Broward County. Its proximity to Holy Cross Hospital and its surrounding medical office district, provides significant daily patient and physician exposure.

Liberty plans to open six additional dispensaries in Florida by Q1 of 2018.

For more information on Liberty please visit  

About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. ("Liberty") is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal.  Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities.  Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer.  Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients. 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's future expansion and growth strategies, the Company's intentions to open dispensary locations in various regions in Florida and the Company's expectations in respect of the future growth of medical cannabis as a treatment option in Florida. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.


SOURCE Liberty Health Sciences Inc.

PR Newswire

Last updated on: 18/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.